 
        Alx Oncology
Biotechnology, 323 Allerton Ave, South San Francisco, California, 94080, United States, 11-50 Employees
 Phone Number: 65********
    Phone Number: 65********
            Who is ALX ONCOLOGY
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridg...
Read More
 
    - 
          Headquarters: 323 Allerton Ave, South San Francisco, California, 94080, United States 
- 
          Date Founded: 2015 
- 
          Employees: 11-50 
- 
          Active Tech Stack: See technologies 
            Industry: Biotechnology
            
              SIC Code: 8733
              |
              NAICS Code: 541715 |
              
                Show More
          
      Does something look wrong? Fix it. | View contact records from ALX ONCOLOGY
ALX Oncology Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
              
              Free credits every month
            
Frequently Asked Questions Regarding ALX Oncology
Answer: ALX Oncology's headquarters are located at 323 Allerton Ave, South San Francisco, California, 94080, United States
Answer: ALX Oncology's phone number is 65********
Answer: ALX Oncology's official website is https://alxoncology.com
Answer: ALX Oncology's SIC: 8733
Answer: ALX Oncology's NAICS: 541715
Answer: ALX Oncology has 11-50 employees
Answer: ALX Oncology is in Biotechnology
Answer: ALX Oncology contact info: Phone number: 65******** Website: https://alxoncology.com
Answer: ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncologys lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.
Premium Sales Data for Prospecting
- 
                Sales data across over 200M records 
- 
                Up-to-date records (less decayed data) 
- 
                Accurate Email Lists (real-world tested) 
- 
                Powerful search engine and intuitive interface 
 
Sign in to CIENCE GO Data to uncover contact details
            
            Free credits every month